GLAXF - GlaxoSmithKline plc (GSK) CEO Emma Walmsley on Q1 2022 Results - Earnings Call Transcript
GlaxoSmithKline plc (GSK) Q1 2022 Results Conference Call April 27, 2022 07:00 AM ET Company Participants Nick Stone - Head of Global Investor Relations Emma Walmsley - Chief Executive Officer Iain Mackay - Chief Financial Officer Deborah Waterhouse - Chief Executive Officer, ViiV Healthcare Brian McNamara - Chief Executive Officer, GSK Consumer Health Luke Miels - Chief Commercial Officer Roger Connor - President, Vaccine and Global Health Hal Barron - Chief Scientific Officer Conference Call Participants Graham Parry - Bank of America Merrill Lynch James Gordon - JPMorgan Chase & Co Laura Sutcliffe - UBS Investment Bank Timothy Anderson - Wolfe Research, LLC Kerry Holford - Joh. Berenberg, Gossler& Co. KG Peter Welford - Jefferies LLC Iain Simpson - Barclays Mark Purcell - Morgan Stanley Simon Baker - Redburn Presentation Operator Good afternoon, ladies and gentlemen, and welcome to the Analyst Call for the GSK First Quarter 2022 Results. I
For further details see:
GlaxoSmithKline plc (GSK) CEO Emma Walmsley on Q1 2022 Results - Earnings Call Transcript